• Skip to main content
  • Skip to primary sidebar

Tracking Health and Wellness Applications of Brain Science

Spanish
sb-logo-with-brain
  • Resources
    • Monthly eNewsletter
    • Solving the Brain Fitness Puzzle
    • The SharpBrains Guide to Brain Fitness
    • How to evaluate brain training claims
    • Resources at a Glance
  • Brain Teasers
    • Top 25 Brain Teasers & Games for Teens and Adults
    • Brain Teasers for each Cognitive Ability
    • More Mind Teasers & Games for Adults of any Age
  • Virtual Summits
    • 2019 SharpBrains Virtual Summit
    • Speaker Roster
    • Brainnovations Pitch Contest
    • 2017 SharpBrains Virtual Summit
    • 2016 SharpBrains Virtual Summit
    • 2015 SharpBrains Virtual Summit
    • 2014 SharpBrains Virtual Summit
  • Report: Pervasive Neurotechnology
  • Report: Digital Brain Health
  • About
    • Mission & Team
    • Endorsements
    • Public Speaking
    • In the News
    • Contact Us

Click Therapeutics

Could I be wrong? Exploring cognitive bias, curiosity, intellectual humility, and lifelong learning

November 30, 2021 by SharpBrains

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing eight time­ly sci­en­tif­ic and indus­try news plus a few fun teasers to appre­ci­ate our unique human brains.

#1. Could I be wrong? Explor­ing research on cog­ni­tive bias, curios­i­ty, intel­lec­tu­al humil­i­ty, and life­long learning

“None of us thinks that our beliefs and atti­tudes are incor­rect; if we did, we obvi­ous­ly wouldn’t hold those beliefs and atti­tudes. Yet, despite our sense that we are usu­al­ly cor­rect, we must accept that our views may some­times turn out to be wrong. This kind of humil­i­ty isn’t sim­ply virtuous—the research sug­gests that it results in bet­ter deci­sions, rela­tion­ships, and out­comes. So, the next time you feel cer­tain about some­thing, you might stop and ask your­self: Could I be wrong?”

#2. Great inter­view on bilin­gual­ism, sports, edu­ca­tion and neu­ro­plas­tic­i­ty — en español

#3. Should old­er politi­cians, and oth­er lead­ers, under­go cog­ni­tive test­ing? The debate con­tin­ues … here are some good com­ments from the online debate we had last summer:

  • PRO: “Def­i­nite­ly. We rou­tine­ly screen appli­cants for a wide range of jobs. Apply for the police, you will be test­ed. Join the mil­i­tary, you will be eval­u­at­ed. Should we not know if a can­di­date for the high­est posi­tion in the coun­try has a seri­ous emo­tion­al, intel­lec­tu­al or psy­cho­log­i­cal impairment?”
  • CON: “I dis­agree because these tests are very bad at pre­dict­ing how good some­one would be in lead­ing a coun­try. It doesn’t require the abil­i­ty to store a lot of infor­ma­tion in your work­ing mem­o­ry. Being a good leader requires only one essen­tial thing: hav­ing the right priorities.”
  • IT DEPENDS: “Who makes the test? What cog­ni­tive met­rics do we use? The bias­es in that design could lead to sig­nif­i­cant unex­pect­ed or even inten­tion­al­ly skewed results.”

#4. Click Ther­a­peu­tics rais­es fur­ther $52M to build up dig­i­tal ther­a­peu­tics pipeline for depres­sion, insom­nia, smok­ing ces­sa­tion and more

What a year for Click and for dig­i­tal therapeutics!

#5. The Amer­i­can Med­ical Association’s (AMA) to ease access to remote Cog­ni­tive Behav­ioral Ther­a­py Monitoring

The road to heav­en is paved with good decisions…

#6. FDA-approved, Cybin-spon­sored clin­i­cial tri­al to mea­sure ketamine’s impact on the brain via Ker­nel Flow neu­roimag­ing helmet

“The word psy­che­del­ic means ‘mind-man­i­fest­ing,’ but what has been miss­ing is use­ful ‘mind-imaging’—the abil­i­ty to dynam­i­cal­ly trace the neur­al cor­re­lates of human con­scious expe­ri­ence. Con­ven­tion­al neu­roimag­ing just isn’t dynam­ic enough to study the psy­che­del­ic expe­ri­ence in the brain as it hap­pens. This study of ketamine’s psy­che­del­ic effects while wear­ing head­gear equipped with sen­sors to record brain activ­i­ty could open up new fron­tiers of under­stand­ing” — Dr. Alex Belser, Cybin’s Chief Clin­i­cal Officer

#7. Bea­con Biosig­nals rais­es $27M to scale EEG, AI-based neu­ro­bio­mark­er dis­cov­ery platform

“ana­lyz­ing EEGs is labor inten­sive and inter­pre­ta­tion of these tests can vary from one clin­i­cian to another..…Beacon Biosig­nals has assem­bled what it claims is one of the world’s largest clin­i­cal EEG data­bas­es. By apply­ing its pro­pri­etary machine-learn­ing algo­rithms to the data­base, the com­pa­ny says it has iden­ti­fied neurobiomarkers—biological indi­ca­tors that are asso­ci­at­ed with cer­tain groups of patients, drug activ­i­ty, and ther­a­peu­tic efficacy.”

#8. Amy­loid-relat­ed imag­ing abnor­mal­i­ties (ARIA) found in approx­i­mate­ly 40% of patients tak­ing “Alzheimer’s drug” Aduhelm

Not good, yet com­plete­ly pre­dictable, and let’s remem­ber this is for a “treat­ment” cost­ing as much as $100,000/ year with exact­ly ZERO proven clin­i­cal ben­e­fit: “…The researchers found 425 cas­es in the com­bined adu­canum­ab group expe­ri­enced ARIA (41.3%), and ARIA-ede­ma was iden­ti­fied in 362 patients or 35.2%. Of them, 94 (26%) had symp­toms, such as headache, con­fu­sion, dizzi­ness and nau­sea. They found ARIA-micro­he­m­or­rhage and ARIA-super­fi­cial sidero­sis in 197 patients (19.1%) and 151 patients (14.7%), respectively.”

Final­ly, Let’s Thank our unique Human Brains and Minds with a few fam­i­ly-friend­ly riddles

Q: What does, “you must come and vis­it us some­time!” actu­al­ly mean?

 

Wish­ing you and yours a Hap­py & Healthy Hanukkah, Decem­ber and Christmas,

The Sharp­Brains Team

 

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Education & Lifelong Learning Tagged With: aducanumab, Aduhelm, Alzheimer's drug, Beacon Biosignals, Click Therapeutics, Cognitive Behavioral Therapy Monitoring, cognitive-bias, cognitive-testing, curiosity, Cybin, depression, digital therapeutics, FDA, insomnia, intellectual humility, Kernel Flow, machine-learning, neuroimaging, neuroplasticity, psychedelic, smoking cessation

Click Therapeutics raises further $52M to build up digital therapeutics pipeline for depression, insomnia, smoking cessation and more

November 4, 2021 by SharpBrains

Get­ty Images

With Sanofi still on board, Click Ther­a­peu­tics clos­es $52M series B for dig­i­tal ther­a­peu­tics in depres­sion, chron­ic pain and more (Fierce Biotech):

Anoth­er medtech devel­op­er’s plans to cre­ate dig­i­tal ther­a­peu­tics to treat a wide range of ill­ness­es are click­ing into place, thanks to a third mul­ti­mil­lion-dol­lar invest­ment in Click Ther­a­peu­tics in bare­ly a year. [Read more…] about Click Ther­a­peu­tics rais­es fur­ther $52M to build up dig­i­tal ther­a­peu­tics pipeline for depres­sion, insom­nia, smok­ing ces­sa­tion and more

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: acute coronary syndrome, app-based therapeutics, chronic pain, Click Therapeutics, Clickadian, Clickheart, Clickotine, cognitive, cognitive-exercises, depression, digital therapeutics, FDA clearance, insomnia, Otsuka, smoking cessation, treat migraine, treat schizophrenia

Innovation in COVID times: Otsuka and Click Therapeutics announce fully virtual clinical trial, leveraging Verily’s Project Baseline

March 19, 2021 by SharpBrains

Otsu­ka launch­es piv­otal tri­al of dig­i­tal ther­a­peu­tics for depres­sion (Med­C­i­ty News):

Otsu­ka Phar­ma­ceu­ti­cal is launch­ing a vir­tu­al study to see if dig­i­tal ther­a­peu­tics can reduce depres­sion symptoms.

It’s the next step in a part­ner­ship between the Tokyo-based drug­mak­er and Click Ther­a­peu­tics, a dig­i­tal health start­up that is devel­op­ing pro­grams for smok­ing ces­sa­tion, depres­sion and insom­nia. [Read more…] about Inno­va­tion in COVID times: Otsu­ka and Click Ther­a­peu­tics announce ful­ly vir­tu­al clin­i­cal tri­al, lever­ag­ing Verily’s Project Baseline

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: Alphabet, antidepressants, Click Therapeutics, COVID-19, depression, digital health, mental health, Otsuka, Project Baseline, Verily

Update: Understanding Brain Health via Cosmological Health, and vice versa

December 29, 2020 by SharpBrains

LEFT: SECTION OF CEREBELLUM, WITH MAGNIFICATION FACTOR 40X, OBTAINED WITH ELECTRON MICROSCOPY (DR. E. ZUNARELLI, UNIVERSITY HOSPITAL OF MODENA); RIGHT: SECTION OF A COSMOLOGICAL SIMULATION, WITH AN EXTENSION OF 300 MILLION LIGHT-YEARS ON EACH SIDE (VAZZA ET AL. 2019 A&A). CREDIT: UNIVERSITY OF BOLOGNA

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing fas­ci­nat­ing find­ings, books and resources for life­long brain health.

#1. “The human brain (sec­tion; left image above) func­tions thanks to its wide neu­ronal net­work that is deemed to con­tain approx­i­mate­ly 69 bil­lion neu­rons. On the oth­er hand, the observ­able uni­verse (sec­tion sim­u­la­tion; right image) can count upon a cos­mic web of at least 100 bil­lion galax­ies. With­in both sys­tems, only 30% of their mass­es are com­posed of galax­ies and neu­rons. With­in both sys­tems, galax­ies and neu­rons arrange them­selves in long fil­a­ments or nodes between the fil­a­ments. Final­ly, with­in both sys­tems, 70% of the dis­tri­b­u­tion of mass or ener­gy is com­posed of com­po­nents play­ing an appar­ent­ly pas­sive role: water in the brain and dark ener­gy in the observ­able Uni­verse.” Under­stand­ing Brain Health via Cos­mo­log­i­cal Health, and vice versa

#2. One very smart and gen­er­ous brain to bright­en your day: Indi­an teacher Ran­jitsinh Disale wins annu­al $1M Glob­al Teacher Prize; shares half with 9 finalists

#3. “Of all the qual­i­ties par­ents can cul­ti­vate in their chil­dren, hope and opti­mism are the most pre­cious. We can nur­ture hope and opti­mism in our kids by demon­strat­ing that we always have some con­trol over our envi­ron­ment and our­selves. The future isn’t a tide that’s going to crush us, it’s a wave we’re a part of.” — Made­line Levine, author of Ready or Not. Three favorite 2020 books on par­ent­ing and men­tal health

#4. A superb mem­oir on becom­ing a psy­chother­a­py pio­neer and best­selling writer: Becom­ing Myself, by Irvin D. Yalom

#5. This sur­vey of 2500 fam­i­lies about what ADHD treat­ments seem to work/ not work finds that 49% of par­ents report Exer­cise to be ‘Extreme­ly or Very Effec­tive;’ above any oth­er treatment.

#6. On the dan­gers of “pro­duc­tiz­ing” lifestyle guide­lines that help build brain reserve and delay cog­ni­tive prob­lems; Buy­er beware: The sto­ry of a pricey and “cre­den­tialled” pro­gram to end Alzheimer’s Disease

#7. Now, giv­en that “In a new McK­in­sey report, 62% of employ­ees con­sid­er men­tal health issues a top chal­lenge,” it is good to see grow­ing resources and approach­es aimed at address­ing the chal­lenge: Calm rais­es $75 mil­lion, expands into cor­po­rate men­tal health and wellness

#8. And, step by step, dig­i­tal ther­a­peu­tics are going main­stream: Click Ther­a­peu­tics rais­es $30 mil­lion in debt to advance com­mer­cial­iza­tion of smok­ing ces­sa­tion app Clickotine

#9. Nev­er two with­out three: Pear Ther­a­peu­tics rais­es $80M; finds cost sav­ings of $2,150 per patient with opi­oid use disorder

#10. Final­ly, we asked our team and trust­ed advi­sors to com­pile a list of ideas to stay sane and healthy in the months ahead, pri­or­i­tiz­ing habits shown to pro­mote brain health, resilience and pos­i­tive neu­ro­plas­tic­i­ty: Enjoy these 3 New Year Res­o­lu­tions and 36 Ideas for a Hap­pi­er & Health­i­er 2021

Wish­ing you a safe, healthy and hap­py New Year

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, SharpBrains Monthly eNewsletter, Technology & Innovation Tagged With: adhd, ADHD-Treatment, Books, brain, brain health, brain-reserve, Calm, Click Therapeutics, cognitive, cognitive problems, digital therapeutics, mental health, Neurons, neuroplasticity, Pear Therapeutics, Psychotherapy, resilience, treatments

Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine

December 4, 2020 by SharpBrains

Click Ther­a­peu­tics Secures $30M in Growth Cap­i­tal from K2 HealthVen­tures to Expand Oper­a­tions (press release):

Click Ther­a­peu­tics, Inc. (“Click”), a leader in Dig­i­tal Ther­a­peu­tics™ solu­tions as pre­scrip­tion med­ical treat­ments, today announced $30 mil­lion in debt financ­ing from K2 HealthVen­tures (K2HV), a health­care-focused spe­cial­ty finance com­pa­ny, to accel­er­ate com­mer­cial­iza­tion of its lead­ing smok­ing ces­sa­tion solu­tion, Click­o­tine™, and to advance its pipeline of clin­i­cal­ly-val­i­dat­ed dig­i­tal ther­a­peu­tics [Read more…] about Click Ther­a­peu­tics rais­es $30 mil­lion in debt to advance com­mer­cial­iza­tion of smok­ing ces­sa­tion app Clickotine

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Technology & Innovation Tagged With: Click Therapeutics, Clickotine, digital therapeutics, K2 HealthVentures, medical treatments, neurotechnologies, non-invasive neurotechnologies, prescription

Update: A life of cognitive and physical exercise helps you stay sharp in your 70s and beyond

September 25, 2020 by SharpBrains

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing 13 fas­ci­nat­ing brain research find­ings, use­ful resources–and a brain teas­er to test your atten­tion skills.

#1. Good news of the month: Elders today are in sig­nif­i­cant­ly bet­ter shape–physically and cognitively–than three decades ago

#2. A dis­tinc­tion WITH a dif­fer­ence: Actu­al, sus­tained practice–not mere knowledge–is need­ed to har­ness neu­ro­plas­tic­i­ty and improve cog­ni­tion over time

#3. “Be mind­ful that with the rapid changes we are expe­ri­enc­ing, our brains are going through accel­er­at­ed learn­ing. Our brains get tired just as our bod­ies would if we ran a marathon with­out train­ing.” How COVID-relat­ed stress can dis­rupt your brain cir­cuits and nine tips to pre­vent it

#4. Yes, Yes, and Yes. To har­ness our best selves, “Tem­per your empa­thy, train your com­pas­sion, and avoid the news”

#5. Things start ear­ly. Marsh­mal­low Test with a twist: 3- and 4‑year-olds kids dis­play more self-con­trol when their rep­u­ta­tion is at stake

#6. Which is why we look for­ward to see­ing 9,000+ stu­dents, plus their many teach­ers and admin­is­tra­tors, fur­ther devel­op their unique brains and minds in years ahead: Help­ing shape the future of life­long learn­ing via SEK Edu­ca­tion Group

#7. “… it would cer­tain­ly be pre­ma­ture to sug­gest that mov­ing to a high alti­tude state would improve a child’s ADHD symp­toms. How­ev­er, the find­ings high­light the val­ue of keep­ing an open mind in efforts to under­stand the devel­op­ment of ADHD and the role nat­ur­al envi­ron­ments may play in poten­tial­ly alle­vi­at­ing it.” Study finds sur­pris­ing cor­re­la­tion between states’ ele­va­tion and ADHD prevalence

#9. Time to start pay­ing seri­ous atten­tion to the brain/ cog­ni­tive side effects of com­mon med­ica­tions. Anti­cholin­er­gic drugs found to sig­nif­i­cant­ly increase risk of cog­ni­tive decline, espe­cial­ly among those with Alzheimer’s Dis­ease bio­mark­ers or genet­ic predisposition

#10. Fas­ci­nat­ing: “After a 14-day train­ing peri­od … visu­ospa­tial skills improved by 40%. This increase in visu­ospa­tial abil­i­ty was shown to be direct­ly respon­si­ble for a reduc­tion in motion sick­ness by 51% in the sim­u­la­tor … and a 58% reduc­tion in the on-road tri­al.” Study: Self-dri­ving cars will increase motion sickness…unless we retrain our brains to improve visu­ospa­tial skills

#11. Behav­ioral health and neu­ro­plas­tic­i­ty meet big phar­ma to hope­ful­ly address a huge need. Click Ther­a­peu­tics and Boehringer Ingel­heim part­ner to devel­op and mar­ket a dig­i­tal ther­a­peu­tic to treat schizophrenia

#12. Neu­ralink: Thumbs up or down?

#13. Brain teas­er: Did you notice the numer­i­cal error as it hap­pened? If not, feel free to go back and find it now 🙂

 

Wish­ing you a safe and healthy October,

 

Alvaro Fer­nan­dez and the Sharp­Brains Team

Share this:

  • Tweet
  • Email
  • Print
  • More
  • Share on Tumblr
  • Pock­et

Filed Under: Brain/ Mental Health, Education & Lifelong Learning, Technology & Innovation Tagged With: adhd, anticholinergic drugs, Behavioral Health, Boehringer Ingelheim, brain teaser for adults, brain training, brain-teaser, brains, Click Therapeutics, cognitive, cognitive side effects, digital therapeutic, improve-cognition, Lifelong-learning, marshmallow test, mindful, Neuralink, neuroplasticity, pharma, research, retrain our brains, schizophrenia, SEK Education Group, side effects, stay-sharp, Visuospatial-skills

Next Page »

Primary Sidebar

Top Articles on Brain Health and Neuroplasticity

  1. Can you grow your hippocampus? Yes. Here’s how, and why it matters
  2. How learning changes your brain
  3. To harness neuroplasticity, start with enthusiasm
  4. Three ways to protect your mental health during –and after– COVID-19
  5. Why you turn down the radio when you're lost
  6. Solving the Brain Fitness Puzzle Is the Key to Self-Empowered Aging
  7. Ten neu­rotech­nolo­gies about to trans­form brain enhance­ment & health
  8. Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
  9. What Educators and Parents Should Know About Neuroplasticity and Dance
  10. The Ten Habits of Highly Effective Brains
  11. Six tips to build resilience and prevent brain-damaging stress
  12. Can brain training work? Yes, if it meets these 5 conditions
  13. What are cognitive abilities and how to boost them?
  14. Eight Tips To Remember What You Read
  15. Twenty Must-Know Facts to Harness Neuroplasticity and Improve Brain Health

Top 10 Brain Teasers and Illusions

  1. You think you know the colors? Try the Stroop Test
  2. Check out this brief attention experiment
  3. Test your stress level
  4. Guess: Are there more brain connections or leaves in the Amazon?
  5. Quick brain teasers to flex two key men­tal mus­cles
  6. Count the Fs in this sentence
  7. Can you iden­tify Apple’s logo?
  8. Ten classic optical illu­sions to trick your mind
  9. What do you see?
  10. Fun Mental Rotation challenge
  • Check our Top 25 Brain Teasers, Games and Illusions

Join 12,619 readers exploring, at no cost, the latest in neuroplasticity and brain health.

By subscribing you agree to receive our free, monthly eNewsletter. We don't rent or sell emails collected, and you may unsubscribe at any time.

IMPORTANT: Please check your inbox or spam folder in a couple minutes and confirm your subscription.

Get In Touch!

Contact Us

660 4th Street, Suite 205,
San Francisco, CA 94107 USA

About Us

SharpBrains is an independent market research firm tracking health and performance applications of brain science. We prepare general and tailored market reports, publish consumer guides, produce an annual global and virtual conference, and provide strategic advisory services.

© 2022 SharpBrains. All Rights Reserved - Privacy Policy